June 1, 2020 / 8:52 PM / a month ago

BRIEF-Kaleido Biosciences Intends To Sell $30 Mln Of Common Shares In Offering

June 1 (Reuters) - Kaleido Biosciences Inc:

* KALEIDO BIOSCIENCES ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

* KALEIDO BIOSCIENCES INC - INTENDS TO SELL $30 MILLION OF SHARES OF ITS COMMON STOCK IN OFFERING

* KALEIDO BIOSCIENCES INC - INTENDS TO USE NET PROCEEDS FROM OFFERING TO FUND ITS CONTINUED RESEARCH AND DEVELOPMENT ACTIVITIES

* KALEIDO BIOSCIENCES - CO’S CONTINUED RESEARCH AND DEVELOPMENT ACTIVITIES, INCLUDE ONGOING CLINICAL PROGRAM OF KB109 IN PATIENTS WITH MILD-TO-MODERATE COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below